Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitro
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
It has been established that macrophages and endothelial cells infiltrate peritoneum in the vicinity of tumor implants of epithelial ovarian cancer (EOC). This study investigates whether the interaction of ovarian cancer cells and tumor‐associated macrophages could promote the involvement of endothelial cells in angiogenesis. Macrophage phenotypes were detected by fluorescence‐activated cell sorting, and cytokine/chemokine secretion was measured by enzyme linked immunosorbent assay. The effect of co‐culture of ovarian cancer cells and tumor‐associated macrophage (TAM) cells on endothelial cell migration and tube formation was investigated. Signaling pathway mediators were also evaluated for their potential roles in endothelial cell activation by ovarian cancer cells co‐cultured with TAM cells. Our results showed that higher expression of interleukin‐8 (IL‐8) expression associated with 54.26 ± 34.46% of TAM infiltration of peritoneum was significantly higher than 16.58 ± 17.74% of CD3+ T‐cell by immunofluorescence co‐staining and confocal microscopy. THP‐1 cells exhibited M2‐polarized phenotype markers with high proportion of CD68+, CD206+ and CD204+ markers after phorbol 12‐myristate 13‐acetate (PMA) treatment, After co‐culturing with TAM cells in a transwell chamber system, EOC cells (SKOV3) increased their IL‐8 expression at the level of mRNA and protein. After exposure to the conditioned medium obtained by co‐culturing TAM and SKOV3 cells, the migration and tube formation of endothelial cells were enhanced significantly. Furthermore, the upregulation of IL‐8 expression in ovarian cancer cells induced by macrophages could be inhibited by pyrollidine dithiocarbamate, an inhibitor of nuclear factor (NF)‐ κB signal pathway. We suggest that the interaction of ovarian cancer cells and tumor‐associated macrophages enhances the ability of endothelial cells to promote the progression of ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
Cited by
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Komohara, Y., Fujiwara, Y., Ohnishi, K., & Takeya, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.009 · Cited by 612
Ning, Y., Cui, Y., Li, X., Cao, X., Chen, A., Xu, C., Cao, J., & Luo, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.022 · Cited by 75
Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66
Ciucci, A., Zannoni, G. F., Buttarelli, M., Martinelli, E., Mascilini, F., Petrillo, M., Ferrandina, G., Scambia, G., & Gallo, D. (2016) · Oncotarget · doi:10.18632/oncotarget.10797 · Cited by 27
“Notably, molecular support to our observation in clinical specimens, is provided by data from Wang and colleagues [26], showing, in vitro models, that the interaction of ovarian cancer cells and TAMs enhances the ability of endothelial cells to promote the progression of ovarian cancer.”
Result
Metadata
- Authors
- Wang, X., Zhao, X., Wang, K., Wu, L., & Duan, T.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2013-03-08
- Volume
- 104
- Issue
- 4
- Pages
- 516-523
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2079347162
- Cited by
- 73
- References
- 1
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.